Skip to main content
Premium Trial:

Request an Annual Quote

Don Hardison, Tim Cook, Richard Brennan

Premium
LabCorp has named Don Hardison to be executive vice president and COO, the company said last week.
 
Hardison formerly was president, CEO, and director at Exact Sciences, and also held executive and sales and marketing spots at Siebel Systems, Quest Diagnostics, and SmithKline Beecham.
 

 
Oxford Gene Technology has appointed Tim Cook to its board as a non-executive director, the company said. Cook, who was appointed in April, recently was an executive director at Isis Innovation, and before that was involved in various management roles in the technology sector. Cook also is an adviser to universities and public groups on technology transfer, chairman of the Oxford Science Enterprise Center, and a visiting professor of science entrepreneurship at Oxford University’s Said Business School.
 

 
GeneGo has tapped Richard Brennan to be director of toxicology, a role that will include running the MetaTox Consortium, a public/private systems biology collaborative, the company said last week.
Brennan previously was director of molecular and investigative toxicology at Iconix Biosciences, an associate director of pharmacology and cell biology at Cornerstone Pharmaceuticals, and a senior scientist at OSI Pharmaceuticals.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.